Competition Tests Novo Nordisk’s Grip on Weight-Loss Drug MarketBusiness PenFebruary 4, 2026 February 4, 2026 Novo Nordisk A/S (NYSE: NVO) surprised investors this week by warning that its sales may decline this year, marking the first projected drop since Ozempic...
